ArticleGynecologic oncology2026
Long-term survival outcomes of robotic-assisted versus traditional laparoscopy for the treatment of stage I endometrial cancer: a National Cancer Database analysis.
Article in Gynecologic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Robotic versus laparoscopic and open surgery for endometrial cancer: a systematic review of randomized trials and pooled analysis of conversion rates.Journal of robotic surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo compare the long-term survival outcomes of robotic-assisted versus traditional laparoscopic surgery for treatment of stage I endometrial cancer.
methodsWe performed a retrospective cohort study using the National Cancer Database, including patients with stage I endometrial cancer diagnosed from 2010 to 2017 (with follow-up through 2020) who underwent treatment with either robotic-assisted or traditional laparoscopic surgery. Demographics, clinical characteristics, and outcomes were summarized using descriptive statistics. Overall survival (OS) was compared using a Cox proportional hazard model, adjusting for demographic and clinical factors; hazard ratios and 95% confidence intervals reported.
resultsA total of 127,342 patients with stage I endometrial cancer who underwent minimally invasive surgery were included. The median follow-up among those still known to be alive was 69.7 months. Almost three-quarters (74.5%) received robotic-assisted surgery, while 25.5% received traditional laparoscopic surgery. Demographic and clinical factors were similar between groups. No differences in OS were observed by surgery modality (5-year OS: 91.7% for robotic vs. 91.4% for traditional laparoscopic surgery) and this remained after adjustment for demographic and clinical factors (HR = 1.00, 95% CI 0.96-1.04).
conclusionsThere was no difference in OS for patients with stage I endometrial cancer treated with robotic-assisted versus traditional laparoscopic surgery. These data demonstrate excellent survival outcomes in this cohort and do not favor a robotic-assisted or traditional laparoscopic approach. However, the full extent of a route-of-surgery decision may not be detected given the potential for late recurrences and deaths, highlighting the need for large, prospective studies with long duration of follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.